- Home
- ONVO vs SXTP Comparison
ONVO vs SXTP Comparison
Compare ONVO & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONVO
- SXTP
- Stock Information
- Founded
- ONVO 2007
- SXTP 2010
- Country
- ONVO United States
- SXTP United States
- Employees
- ONVO N/A
- SXTP N/A
- Industry
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- ONVO Health Care
- SXTP Health Care
- Exchange
- ONVO Nasdaq
- SXTP Nasdaq
- Market Cap
- ONVO 3.0M
- SXTP 2.7M
- IPO Year
- ONVO N/A
- SXTP 2023
- Fundamental
- Price
- ONVO $1.87
- SXTP $2.95
- Analyst Decision
- ONVO
- SXTP Hold
- Analyst Count
- ONVO 0
- SXTP 1
- Target Price
- ONVO N/A
- SXTP N/A
- AVG Volume (30 Days)
- ONVO 347.1K
- SXTP 4.8M
- Earning Date
- ONVO 05-30-2025
- SXTP 05-14-2025
- Dividend Yield
- ONVO N/A
- SXTP N/A
- EPS Growth
- ONVO N/A
- SXTP N/A
- EPS
- ONVO N/A
- SXTP N/A
- Revenue
- ONVO $122,000.00
- SXTP $681,345.00
- Revenue This Year
- ONVO $59.08
- SXTP $95.50
- Revenue Next Year
- ONVO $18.24
- SXTP $80.78
- P/E Ratio
- ONVO N/A
- SXTP N/A
- Revenue Growth
- ONVO N/A
- SXTP 168.70
- 52 Week Low
- ONVO $1.56
- SXTP $1.41
- 52 Week High
- ONVO $21.96
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- ONVO 37.84
- SXTP 56.45
- Support Level
- ONVO $1.56
- SXTP $2.48
- Resistance Level
- ONVO $1.78
- SXTP $3.45
- Average True Range (ATR)
- ONVO 0.24
- SXTP 0.70
- MACD
- ONVO 0.13
- SXTP 0.02
- Stochastic Oscillator
- ONVO 43.06
- SXTP 47.63
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.